-
Tata India Pharma & Healthcare Fund Regular Growth
Equity healthcare
Overview ( as on 13/06/25 )
NAV
₹29.9
Last change
₹-0.08 -0.0%
Fund Size (AUM)
1231.67 Cr
Performance
21.52% (5Y)
Fund Details
Tata India Pharma & Healthcare Fund Regular Growth
as of 13/06/25
AUM
1231.67 Cr
Expense Ratio
2.12 %
Benchmark
Nifty Pharma TR INR
ISIN
INF277K016A9
Fund Manager
Meeta Shetty
Exit Load
0.25% if redeemed within 0-30 days
0% if redeemed after 30 days
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| Tata India Pharma & Healthcare Fund Regular Growth | 13.65% | 24.9% | 21.52% |
| Nifty Pharma TR INR | 22.11% | 23.78% | 22.18% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
11.64% |
Apollo Hospitals Enterprise Ltd |
6.22% |
Cipla Ltd |
5.83% |
Aurobindo Pharma Ltd |
5.73% |
Divi's Laboratories Ltd |
5.63% |
Fortis Healthcare Ltd |
4.9% |
Lupin Ltd |
4.82% |
Aster DM Healthcare Ltd Ordinary Shares |
4.35% |
Wockhardt Ltd |
3.27% |
Dr Reddy's Laboratories Ltd |
3.16% |
Sector Allocation
Healthcare |
97.4% |
Basic Materials |
2.6% |
Asset Allocation
-
91%
Equity
-
9%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Gr
Equity healthcare-
Returns
-
25.09% (5Y)
-
-
SBI Healthcare Opportunities Reg Gr
Equity healthcare-
Returns
-
24.21% (5Y)
-
-
SBI Healthcare Opportunities Reg IDCW-R
Equity healthcare-
Returns
-
24.21% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
22.34% (5Y)
-
-
UTI Healthcare Reg Gr
Equity healthcare-
Returns
-
22.07% (5Y)
-
-
UTI Healthcare Reg IDCW-P
Equity healthcare-
Returns
-
22.07% (5Y)
-
